KATHRYN KERINS: Open Payments
NPI 1114776218 · NEW MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $260 · 2025 $478
Food & beverage: $314Education: $164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $262 |
| Celgene Corporation | 3 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Geron Corporation | 1 | $29 |
| SERVIER PHARMACEUTICALS LLC | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $19 |
| SOBI, INC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $13 |
Products named: VENCLEXTA, REBLOZYL, IMBRUVICA, Nubeqa, RYTELO, EPKINLY, OPDIVO, IDHIFA.
Industry payments across CT — which companies pay providers there.
